Lifeboat Foundation

Can Tesla meet the production timeline for Optimus? Share your thoughts in the comments.

Tesla’s humanoid robot, Optimus, is set to enter production by 2025. Elon Musk announced that low production for internal use will begin next year, with high production for external companies expected in 2026. Optimus Gen 2, featuring a new design, was showcased at the 2024 World Artificial Intelligence Conference in Shanghai. Tesla has been conducting field tests in its gigafactories, indicating progress towards Musk’s timeline for Optimus’ production.

8,519 likes, — unfiltered.politics on October 10, 2024: “BREAKING: #ElonMusk at ‘We, Robot’ event unveils the #TeslaOptimus, says it will be ”biggest product ever of any kind”

I want one, where can I sign up? 🤖

#Musk #Tesla #Cybercab #elon #irobot #werobot

It’s a van. Its seats up to 20 people, it’s autonomous, it can be configured for goods and yes it will look like this IRL. … #tesla #cybervan #autonomus #future #technology #ev

Scientists discovered that the molecule CaMKII helps neurons encode information over seconds, a key process in learning. This challenges previous beliefs about how CaMKII influences synapse-specific plasticity.

A recent study from the Max Planck Florida Institute for Neuroscience, published in Nature, has uncovered a crucial step in how neurons encode information on timescales aligned with the process of learning.

A timing mismatch.

MILAN — Vast Space unveiled the design of the space station it plans to propose to NASA in the next phase of the agency’s program to develop commercial successors to the International Space Station.

The company outlined its plans for the Haven-2 station in a release timed to the opening of the International Astronautical Congress here Oct. 14, describing how it will deploy the station in segments starting in the late 2020s.

Vast has to date focused on Haven-1, the single-module station it plans to launch in the second half of 2025 to be visited by up to four missions for short stays. However, the company has made clear its intent is to compete for the second phase of NASA’s Commercial Low Earth Orbit Destinations, or CLD, program as part of the agency’s ISS transition efforts.

“A Vision for a 100% Hydrogen-Fueled Future In their research and development testing facility, located at the headquarter office outside of Bergen, Norway, Bergen Engines is diligently working toward the development of a 100% hydrogen-fueled engine by the end of this year, and are on track to reach their goal.”

Bergen Engines now increase full natural gas engine range to run on 25% hydrogen in full operation without modification.

The interlocking bricks, which can be repurposed many times over, can withstand similar pressures as their concrete counterparts. Engineers developed a new kind of reconfigurable masonry made from 3D-printed, recycled glass. The bricks could be reused many times over in building facades and internal walls.

What if construction materials could be put together and taken apart as easily as LEGO bricks? Such reconfigurable masonry would be disassembled at the end of a building’s lifetime and reassembled into a new structure, in a sustainable cycle that could supply generations of buildings using the same physical building blocks.

That’s the idea behind circular construction, which aims to reuse and repurpose a building’s materials whenever possible, to minimize the manufacturing of new materials and reduce the construction industry’s “embodied carbon,” which refers to the greenhouse gas emissions associated with every process throughout a building’s construction, from manufacturing to demolition.

Fever temperatures rev up immune cell metabolism, proliferation and activity, but they also — in a particular subset of T cells — cause mitochondrial stress, DNA damage and cell death, Vanderbilt University Medical Center researchers have discovered.

The findings, published Sept. 20 in the journal Science Immunology, offer a mechanistic understanding for how cells respond to heat and could explain how chronic inflammation contributes to the development of cancer.

The impact of fever temperatures on cells is a relatively understudied area, said Jeff Rathmell, PhD, Cornelius Vanderbilt Professor of Immunobiology and corresponding author of the new study. Most of the existing temperature-related research relates to agriculture and how extreme temperatures impact crops and livestock, he noted. It’s challenging to change the temperature of animal models without causing stress, and cells in the laboratory are generally cultured in incubators that are set at human body temperature: 37 degrees Celsius (98.6 degrees Fahrenheit).

A BREAKTHROUGH cancer treatment “could be the cure” for a “death sentence” form of the disease after making tumours disappear.

The experimental approach has seen remarkable success in some brain cancer patients — with experts saying it could be available on the NHS within five years.